Mitochondrial inhibitor as a new class of insulin sensitizer.
about
AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetesMechanisms of insulin resistance in obesityInduction of Posttranslational Modifications of Mitochondrial Proteins by ATP Contributes to Negative Regulation of Mitochondrial FunctionRegulation of hepatic pyruvate dehydrogenase phosphorylation in offspring glucose intolerance induced by intrauterine hyperglycemia.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Metformin Accelerates Glycolytic Lactate Production in Cultured Primary Cerebellar Granule Neurons.Toona Sinensis ameliorates insulin resistance via AMPK and PPARγ pathways.Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes.Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation.Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation.Regulation of malonyl-CoA-acyl carrier protein transacylase network in umbilical cord blood affected by intrauterine hyperglycemia.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.3,5-Diiodo-L-Thyronine Affects Structural and Metabolic Features of Skeletal Muscle Mitochondria in High-Fat-Diet Fed Rats Producing a Co-adaptation to the Glycolytic Fiber Phenotype.Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification.
P2860
Q27300811-C2574717-830D-4CF3-88F0-7ECB9EFFED92Q34331776-3696EBAC-26BD-4922-B96A-4A89B3FB658DQ35941171-56C11371-AE29-4046-B926-B0FA23A2CB5AQ37716524-C68C72F0-98D1-42C7-9923-F8B8193D17D7Q38668187-ACEB420A-D1E7-4132-9EE2-D9922A67418EQ38688703-B97948E0-835E-4380-AB0E-31FCD000D94EQ38879146-47D4D93B-DB12-42C7-9BEC-04E2E8A6E35FQ38987895-8584D6D0-2D2A-4871-9589-66220A7A46F3Q41004903-84FE6469-D01C-48F2-B9BC-8F75586A2721Q41114295-9F5FC8D0-D423-4692-935C-797EE031FAD9Q46124072-803F4166-EE12-4120-B142-1B8E4A16A1C6Q47141856-30FE5E18-4B24-4810-A81F-3FB2943BC6F8Q47402228-C27085EA-D5B6-46C2-8627-37F56C3FA56FQ52338795-9AFCDB59-27F3-457B-BA30-ABE31A1B45CAQ55416886-B764B101-2A51-46B9-BD0F-AEEA349D0609
P2860
Mitochondrial inhibitor as a new class of insulin sensitizer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mitochondrial inhibitor as a new class of insulin sensitizer.
@en
type
label
Mitochondrial inhibitor as a new class of insulin sensitizer.
@en
prefLabel
Mitochondrial inhibitor as a new class of insulin sensitizer.
@en
P2860
P1476
Mitochondrial inhibitor as a new class of insulin sensitizer.
@en
P2093
Jianping Ye
Yong Zhang
P2860
P304
P356
10.1016/J.APSB.2012.06.010
P577
2012-08-01T00:00:00Z